All terms in MeSH
| Label | Id | Description |
|---|---|---|
| Ethylene Glycols | D02.033.455.250 | |
| Tuberculosis, Central Nervous System | C01.150.252.223.850 | |
| Mitogen-Activated Protein Kinase 6 | D12.776.476.450.169.875 | |
| Fibrinopeptide A | D23.119.500 | |
| Immediate Dental Implant Loading | E04.650.230.500.350 | |
| Inosine Triphosphate | D13.695.827.519.800 | |
| Inosine Nucleotides | D13.695.827.519 | |
| ABO Blood-Group System | D23.050.705.230.031 | |
| Water Deprivation | F01.658.938 | |
| Motivation | F01.658 | |
| HLA-DRB3 Chains | D23.050.705.552.450.400.440.333.750 | |
| Cervical Vertebrae | A02.835.232.834.151 | |
| Metabolic Side Effects of Drugs and Substances | C25.100.812 | |
| Leigh Disease | C18.452.660.520 | |
| Copper Transporter 1 | D12.776.543.585.937.762.500 | |
| SLC31 Proteins | D12.776.543.585.937.762 | |
| Hair Cells, Ampulla | A09.246.300.663.500.500 | |
| Semicircular Ducts | A09.246.300.663.500 | |
| Donor Selection | D046148 | [The procedure established to evaluate the health status and risk factors of the potential DONORS of biological materials. Donors are selected based on the principles that their health will not be compromised in the process, and the donated materials, such as TISSUES or organs, are safe for reuse in the recipients. , The procedure established to evaluate the donated TISSUES or organs prior to selection for reuse. Donated specimens may be disqualified for reuse due to deteriorating conditions and risk factors, such as INFECTIONS, and HEREDITARY DISEASES. ] |
| Bronchiolitis, Viral | C08.381.495.146.135.321 |